An Open-Label Crossover Study To Evaluate Potential Pharmacokinetic Interactions between Oral Oseltamivir and Intravenous Zanamivir in Healthy Thai Adults

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem. Zanamivir is effective against the most prevalent oseltamivir-resistant influenza viruses. A parenteral formulation of zanam...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pukrittayakamee, Sasithon, Jittamala, Podjanee, Stepniewska, Kasia, Lindegardh, Niklas, Chueasuwanchai, Sunee, Leowattana, Wattana, Phakdeeraj, Aphiradee, Permpunpanich, Sutatip, Hanpithakpong, Warunee, Pan-Ngum, Wirichada, Fukuda, Caroline, Panapipat, Salwaluk, Singhasivanon, Pratap, White, Nicholas J., Day, Nicholas P. J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2011
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165358/
https://ncbi.nlm.nih.gov/pubmed/21690287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00159-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares